Previously, we reported 1) a comparison of the cytotoxic effects of naturally occurring hydroxyanthraquinone derivatives, isolated from the root of Rhubarb (Rheum palmatum (Polygonaceae)) and hydroxynaphthoquinone derivatives, isolated from the roots of Lithosperumum erythrorhizon SIEB. et ZUCC. and Macrotomia euchroma (ROYLE) PAULS. (Boraginaceae), using human colorectal (HCT 116) 2) and human hepatoma (Hep G2) 3) cell lines. In addition, we prepared 1,8-di-O-alkylaloe-emodins and 15-amino-, 15-thiocyano-and 15selenochrysophanol derivatives from aloe-emodin, which is one of hydroxyanthraquinone compounds isolated from the root of Rhubarb. A comparison of cytotoxic acivities of the derivatives using the same cancer cell lines were also reported. 4) The present study deals with preparations of chrysophanol and 18-di-O-hexylchrysophanol derivatives having various nucleic acid bases at position of 15 from aloe-emodin and 18-di-O-hexylaloe-emodin, respectively. We also synthesize napthoquinone derivatives having various nucleic acid bases, amines, and thiocyanato (-SCN), selenocyanato (-SeCN) and thioacetyl (-SAc) groups on the side chains of the naphthoquinone skeletons derived from menadione (Vitamin K 3 , 2methylnaphthoquinone). Furthermore, we evaluate the cytotoxic effects of the synthetic derivatives using HCT 116 and Hep G2 cancer cell lines, and compare the effects with those of 5-fluorouracil (5-FU).
due to C-4 and C-8 on the adenine residue, respectively, were observed. Thus, compound 9 was confirmed as 3-[(6amino-9H-purin-9-yl)-methyl]-1,8-bis(hexyloxy)anthracene-9,10-dione. Correlations between proton signals at d 4.94, 4.98 and 4.93 due to the methylene groups on the anthraquinone residues of 10, 11 and 12, respectively, and carbon signals due to C-2 and C-6 at d 150.9 and 136.4, d 150.7 and 143.6, and d 149.3 and 127.9 on the thymine, uracil and 5fluorouracil residues, respectively, were observed. As a result, compounds 10, 11 and 12 are confirmed as 1-([4,5-bis (hexyloxy)-9,10-dinoe-9,10-dihydroanthracene-2yl]methyl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-([4,5-bis(hexyloxy)-9,10-dinoe-9,10-dihydroanthracene-2yl]methyl)pyrimidine-2,4(1H,3H)-dione and, 1-([4,5-bis(hexyloxy)-9,10-dinoe-9, 10-dihydroanthracene-2yl]methyl)-5-fluoropyrimidine-2, 4(1H,3H)-dione, respectively. 1,8-Dihydroxyl anthraquinone derivatives having nucleic acid bases were synthesized as follows. 15-Bromochrysophanol 13 4) was reacted with adenine 6, thymine 7, uracil 8 or 5-FU 2 in the presence of NaH in DMF to give compounds 14, 15, 16 and 17 in 18.1%, 57.0%, 68.2% and 45.9% yield, respectively ( Fig. 4 ).
Next, naphthoquinone derivatives having various nucleic acid bases or amines, and thiocyanato (-SCN), selenocyanato (-SeCN) and thioacetyl (-SAc) groups on the side chains of the naphthoquinone skeletons were synthesized. In this study, we aimed to obtain two types of naphthoquinone derivatives (type A and B shown in Fig. 5 ) from menadione 18 (Vitamin K 3 , an easily obtainable compound from commercial suppliers) in order to investigate the structure-cytotoxic activity relationships of the products.
A key 2-bromomethoxy-1,4-dimethoxynaphthalene 19 for the preparation of type A (Fig. 5 ) derivatives was synthesized as follows. Compound 18 was reacted with SnCl 2 in acidic MeOH, followed by treatment with dimethyl-sulfate and K 2 CO 3 in acetone 14) to give 20 in 71.5% yield. Compound 20 was oxidized with KMnO 4 in aqueous pyridine to give compound 21 in 32.3% yield, and then reduced with LiAlH 4 to obtain alcohol 22 (57.1% yield). The alcohol was then reacted with CBr 4 and PPh 3 in ether to give compound 19 (50.3% yield) ( Fig. 6) .
A key 7-bromomethoxy-1,4-dimethoxynaphthalene 23 for the preparation of type B derivatives ( Fig. 5 ) was synthesized as follows. Friedel-Crafts reaction 15) of compound 20 with CH 3 COCl gave 24 in 65.2% yield. The position of the substituted acetyl group (COCH 3 ) of 24 was confirmed from the HMBC spectrum ( Fig. 7) . Correlation between proton signals at d 8.06 and 8.83 due to H-6 and H-8, respectively, and carbon signal at d 198.1, due to the newly introduced acetyl group, and that between the methyl proton signal at d 2.73 of the acetyl group and carbon signals at 133.2 and 124.5 due to C-7 and C-8, respectively, were observed. The NMR data shows compound 24 is 7-acetyl-1,4-dimethoxy-2-methylnaphthalene.
Compound 24 was successively treated with KOH, 16) reduced with LiAlH 4 and brominated with CBr 4 and PPh 3 to give 25, 26 and 23, in 43.5%, 64.7% and 65.8% yield, respectively. Bromide 19 was reacted with adenine, thymine, uracil and 5-fluorouracil in the presence of NaH in DMF to give compounds 27, 28, 29 and 30 in 28.3%, 53.7%, 41.9% and 54.7% yield, respectively (Fig. 8) . The same reactions with bromide 23 afforded compounds 31, 32, 33 and 34 in 57.0, 54.7, 56.6 and 47.8% yield, respectively. Cleavage of the protecting group of 27 was carried out by three different methods; i) hydrolysis with HNO 3 in AcOH, ii) treatment with (NH 4 ) 2 Ce(NO 3 ) 6 (CAN) in aqueous CH 3 CN 14) and iii) treatment with N-bromosuccinimide (NBS) in acidified aqueous tetrahydrofuran (THF). 17) Most of the procedures gave mixtures, although treatment of compounds 28-34 by the method i) afforded the desired products 35, 36, 37, 38, 39, 40 and 41 in 53.2%, 47.8%, 51.7%, 21.9%, 64.1%, 63.5% and 56.1% yield, respectively. Naphthoquinone derivatives having various amines at the side chain in the molecules were synthesized next ( Fig. 9 ). Bromide 19 was reacted with pyrrolidine, 1-methylpiperazine, morpholine, imidazole, theophylline and theobromine in THF to give compounds 42, 43, 44, 45, 46 and 47 in 64.2, 51.4, 62.6, 46.7, 32.6 and 55.5% yield, respectively. Bromide 23 was reacted with morpholine in THF to give compound 48 in 49.8% yield. Bromide 23 was reacted with theophylline and theobromine in the presence of NaH in DMF to afford compounds 49 and 50 in 38.4% and 69.8% yield, respectively. Cleavage of the protecting group of 42 and 43 by the method iii) (described earlier) gave compounds 51 and 52 in 59.0% and 54.8% yield, respectively. Compounds 44 and 46 were deprotected by the method ii) to afford compounds 53 and 54 in 63.5% and 53.7% yield, respectively. The protecting group of 47 was cleaved by the method i) to give compound 55 in 58.6% yield. Unfortunately, cleavage of the protecting group of 45 gave a mixture of products using each of the three methods. The cleavages of the protecting group of compounds 48-50 by the method iii) gave compounds 56-58 in 49.5%, 41.2% and 38.5% yield, respectively.
Finally, type A and B naphthoqinone derivatives ( Fig. 5 ) having thiocyanato (-SCN), selenocyanato (-SeCN) and thioacetyl (-SAc) groups at the side chains of the molecules were prepared. In these preparations, bromide 19 and bromide 23 were also utilized as starting materials. Bromide 19 was reacted with KSCN, KSeCN and KOAc to give naphthalene derivatives 59-61 in 73.6%, 76.4% and 55.3% yield, respectively. Reactions of bromide 23 with KSCN, KSeCN and KOAc gave naphthalene derivatives 62-64 in the yields of 65.3%, 52.2% and 48.3% yield, respectively. Cleavage of the protecting groups of compounds 59-64 was carried out by the three methods described earlier. Method i) was used to obtain compounds 65-70 in 46.6%, 38.9%, 45.3%, 42.3%, 41.8% and 71.5% yield, respectively. 
Pharmacological Results and Discussion
Cytotoxic effects of all anthraquinone and naphthoquinone derivatives prepared in this study were tested against HCT 116 and Hep G2 cancer cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 18) and compared with those of 5-FU, which has been used clinically. In this study, the effects are represented by IC 50 values i.e., concentration of compound required to give 50% inhibition of cell growth. Although multidrug resistance 1 (MDR 1) (P-glycoprotein; P-gp) 2) is overexpressed in Hep G2 cells, it is barely expressed in HCT 116 cells. 3) P-gp acts as an efflux pump to remove several antitumor agents such as Ca 2ϩ antagonists, cyclosporine and digoxin from cells. 19) Table 1 shows the comparison of cytotoxic effects of 1,8di-O-hexylchrysophanol derivatives 9-12 and chrysophanol derivatives 14-17 having nucleic acid bases at position 15 with those of clinically used 5-fluorouracil (5-FU) 2 against HCT 116 and Hep G2 cancer cells. In the case of compounds 9-12, 9 and 10 substituted with adenine and thymine, respectively, showed more potent effects on the both cell lines (IC 50 : 8.1Ϯ1.1 and 3.8Ϯ0.11 mM, respectively, on HCT 116 cells, and 10.4Ϯ3.6 and 4.2Ϯ0.4 mM, respectively, on Hep G2 cells) than those of 2 (IC 50 : 45.0Ϯ6.8 and 50.8Ϯ3.7 mM on HCT 116 and Hep G2 cells, respectively). Compounds 11 and 12 substituted with uracil and 5-fluorouracil, respec-tively, have, however, slightly greater effects (IC 50 : 29.3Ϯ6.9 and 39.6Ϯ4.4 mM, respectively) on HCT 116 cells than that of 2. Using Hep G2 cells, compound 12 displayed only a marginally greater effect (IC 50 : 45.3Ϯ10.5 mM) than that of 2, while the effect of compound 11 (IC 50 : more than 100 mM) was weaker than that of 2 on the same cells. We also tested the biological effect of chrysophanol derivatives 14-17 substituted with adenine, thymine, uracil or 5-fluorouracil, respectively. All these derivatives showed greater effects than those of 2 both on TCT 116 cells and Hep G2 cells. Among these compounds, 14, 16 and 17 had potent effects both on HCT 116 cells (IC 50 : 2.8Ϯ0.4-7.8Ϯ0.4 mM) and Hep G2 cells (IC 50 : 3.1Ϯ0.4-9.8Ϯ0.6 mM), although the exact IC 50 values for 15 were not obtained because of problems with turbidity.
Next, cytotoxic effects of type A and B naphthoquinone derivatives having nucleic acid bases ( Fig. 8 ) were evaluated and compared with those of 2 (5-FU). Table 2 shows the cytotoxic effects of compounds 35-37 (type A) and compounds 38-41 (type B). Both types of compounds had potent effects on HCT 116 cells (IC 50 : 1.8Ϯ0.1-3.0Ϯ0.1 mM for 35-37 and 1.8Ϯ0.1-8.6Ϯ0.6 mM for 38-41) and Hep G2 cells (IC 50 : 2.3Ϯ0.1-4.1Ϯ0.2 mM for 35-37 and 2.5Ϯ0.2-7.8Ϯ0.3 mM for 38-41). The effects of type A and type B derivatives against HCT 116 and Hep G2 cells were 5.2-25.0 and 6.5-22.1 times higher than those of 2 (IC 50 : 45.0Ϯ6.8 and 50.8Ϯ3.7 mM, respectively). However, there was no significant difference between the effects of type A derivatives and those of type B derivatives.
Amino derivatives 51-54 (type A) and 56-58 (type B) also showed more potent effects on HCT 116 cells (IC 50 : 1.6Ϯ0.1-6.7Ϯ0.1 mM) and Hep G2 cells (IC 50 : 2.1Ϯ0.3-8.5Ϯ0.4 mM) (Table 3) than the corresponding effect of compound 2. In this case, no significant difference between type A and type B amines was also observed.
Finally, cytotoxic effects of type A and B naphthoquinone derivatives 65-67 and 68-70, respectively, having -SCN, -SeCN and -SAc groups (Fig. 10 ) were evaluated and compared with those of 2 (5-FU) ( Table 4 ). All these type A and B compounds displayed a greater biological effects (IC 50 : 2.7Ϯ0.1-16.0Ϯ0.5 mM on HCT 116 cells, 4.4Ϯ0.1-20.9Ϯ1.4 mM on Hep G2 cells) than compound 2 using both cell lines. A comparison of the effects shown in Table 4 between type A and type B compounds illustrates that there is no difference in the structure-activity relationships. Interes-tigly, the effect of compounds 65 and 67-70 on HCT 116 cells was greater than the corresponding effect on Hep G2 cells. However, in the case of compound 66, both cell lines were affected to a similar extent. Among these compounds 65-70, compound 68 (type B derivative having -SCN group) in particular displayed a remarkably potent effects against both the HCT 116 cells (IC 50 : 2.7Ϯ0.1 mM) and Hep G2 cells (IC 50 : 4.4Ϯ0.1 mM) lines.
Conclusion
In this study, anthraquinone and naphthoquinone derivatized with various nucleic acid bases, amines and thiocyanato, selenocyanato or thioacetyl groups were synthesized. From 1,8-di-O-hexyl-15-O-tosylchrysophanol 5, 1,8di-O-hexylchrysophanol derivatives 9-12 substituted with adenine, thymine, uracil and 5-fluorouracil, respectively, were prepared. Starting from 15-bromochrysophanol 13, chrysophanol derivatives 14-17 substituted with adenine, thymine, uracil and 5-fluorouracil, respectively, were prepared. For the preparations of naphthoquinone derivatives, 1,4-dimethoxynaphthalene 20 derived from menadione 18 (Vitamin K 3 ) was used as a key intermediate. From compound 20, both type A and type B bromides (11-bromo-1,4dimethoxynaphthalene 19 and 7-bromomethyl-1,4-dimethoxynaphthalene 23, respectively) were obtained. Substitutions of 19 with nucleic acid bases, amines and potassium salts (KSCN, KSeCN and KSAc), followed by cleavage of the protecting groups, gave 35, 36 and 37 as type A derivatives bearing thymine, uracil and 5-fluolouracil moieties, respec- a) Each experiment was performed in duplicate wells, and drug treatments were performed separately three times. b) IC 50 values (meanϮS.D.) are the concentrations at which 50% of the cells are inhibited from growing. c) IC 50 values more than 100 mM are indicated as Ͼ100. d) Precise values for compound 15 were not obtained because the turbidity of the solution was too great at the concentrations of compound giving 50% growth inhibition. tively. Compounds 51-55 represent the same type of derivatives having amines (pyrrolidine, 1-methylpiperazine, morpholine, imidazole, theophylline or theobromine, respectively). Likewise compounds 65-67 are corresponding derivatives having -SCN, -SeCN and -SAc groups, respectively. Similarly, from bromide 23, the type B naphthoquinone derivatives 38-41 having adenine, thymine, uracil and 5-fluorouracil, respectively, were synthesized. The same type derivatives 56-58 having morpholine, theophylline and theobromine, respectively, and the same type derivatives 68-70 having -SCN, -SeCN and -SAc, respectively, were also obtained.
The cytotoxic effects of each synthetic derivative was evaluated using the HCT 116 cell and Hep G2 cancer cell lines. These cell lines were chosen because MDR 1 (P-glycoprotein, P-gp) 2) is known to be overexpressed in the Hep G2 cell lines but barely expressed in the HCT 116 cell lines. 3) The cytotoxic activity of each compound was then compared to that of 5-fluorouracil (5-FU). Among anthraquinones 9-17, 1,8-di-O-hexylchrysophanols 9 and 10 and chrysophanols 14, 16 and 17 showed potent effects both on HCT 116 and Hep G2 cells (Table 1) . Interestingly, compounds 14 and 16 displayed enhanced activity using both Hep G2 cells and HCT 116 cells. Indeed, of all the anthraquinones, 14 and 16 seemed to be the strongest inhibitors of the efflux function of P-gp. Moreover, all the naphthoquinone derivatives synthesized in this study also displayed potent effects both on HCT 116 and Hep G2 cell lines (see Tables 2-4 ). We analized the structure-activity relationships between type A and B derivatives and the various substituents. However, no firm conclusions could be made from this analysis. Interestingly, however, many of the compounds had potent effects against Hep G2 cells, which overexpress P-gp. We anticipate these derivatives may help to overcome the problem of drug excretion from cancer cells stably expressing P-gp. Indeed, excretion of anticancer agents is a major cause of multidrug resistance. Further work is required to establish the precise structure-activity relationship for the various derivatives in terms of their affinity for the target proteins and the corresponding intracellular accumulation.
Experimental
General Methods Reagent-grade chemicals and solvents were obtained from commercial suppliers. The melting points (mp) were determined using a Yanagimoto micromelting point apparatus and were uncorrected. Kieselgel 60 F 254 (E. Merck, Germany) was used in thin-layer chromatography (TLC). Spots were detected by spraying plates with 1 : 9 Ce(SO 4 ) 2 -10% H 2 SO 4 reagent, followed by heating the plates at 200°C for 4-5 min. Column chromatography was carried out using Kieselgel 60 (E. Merck), then the eluates were monitored by TLC. 1 H-and 13 C-NMR spectroscopy investigations were carried out at 500 and 125 MHz, respectively, and 1 H-1 H and 1 H-13 C correlation spectroscopy (COSY) and HMBC spectra were obtained using a JEOL JNM-A500 FT-NMR spectrometer. Tetramethylsilane was used as an internal standard. The chemical shifts are given in ppm. The multiplicities of the 1 H-NMR signals are indicated as s (singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet) and m (multiplet). Electron impact mass spectra (EI-MS) were recorded using a JEOL JMS-DX 300 mass spectrometer. First-atom-bombardment mass spectra (FAB-MS) and high resolution mass (HR-MS) spectra were recorded using a JEOL JMS-700 mass spectrometer.
3-[(6-Amino-9H-purin-9-yl)methyl]-1,8-bis(hexyloxy)anthracene-9,10-dione (9) A solution of 5 (110 mg, 0.19 mmol), NaH (42.5 mg, 1.8 mmol) and 6 (118.5 mg, 0.88 mmol) in DMF (5 ml) was stirred at 85°C for 35 h. The reaction mixture was poured into ice-water (20 ml) and extracted with CHCl 3 (30 mlϫ2). The organic extracts were successively washed with brine and water, dried over absolute MgSO 4 , and then filtered.
The filtrate was evaporated to give a residue, which was subjected to silica gel column chromatography (a gradient of 0-10% MeOH in CHCl 3 ) to afford compound 9 ( 5 Hz, H-2), 5.73 (2H, br s, 6Ј-NH 2 ), 5.43 (2H, s, 15-CH 2 ), 4.11 and 4.03 (each 2H, t, Jϭ6. 6 Hz, 1-or 8-OCH 2 ), 1.88 (4H, m, CH 2 ϫ2), 1.54 (4H, m, CH 2 ϫ2), 1.34 (8H, m, CH 2 ϫ4), 0.91 (6H, m, CH 3 ϫ2). 13 3-[(6-Amino-9H-purin-9-yl)methyl]-1,8-dihydroxyanthracene-9,10dione (14) A solution of 13 (96 mg, 0.29 mmol), NaH (22.0 mg, 0.9 mmol) and 6 (77.4 mg, 0.57 mmol) in DMF (15 ml) was stirred at room temperature for 3 h. The reaction mixture was poured into ice-water (30 ml) and extracted with AcOEt (100 mlϫ3). The organic extracts were successively washed with brine and water, dried over absolute MgSO 4 , and then filtered. The filtrate was evaporated to give a residue, which was subjected to silica gel column chromatography (a gradient of 0-10% MeOH in CHCl 3 ) to afford compound 14 (20.2 mg, 18.1% yield) as yellowish needles (mp more than 300°C 13 1,4-Dimethoxynaphthalene-2-carboxylic Acid (21) KMnO 4 (63.4 g, 0.4 mol) was added to a solution of compound 20 (16.2 g, 80.1 mmol) in pyridine (250 ml) and water (250 ml) before stirring the mixture at 100°C for 24 h. The reaction mixture was filtered and half the filtrate was removed by distillation at reduced pressure. Water (250 ml) was then added to the mixture before extracting with Et 2 O (100 mlϫ3). The organic extracts were successively washed with brine and water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue, which was subjected to column chromatography (a gradient of 0-50% MeOH in CHCl 3 ) to obtain compound 21 (6.0 g, 32.3% yield) as colorless needles (mp 160-162°C). EI-MS: m/z 232 [M] ϩ . HR-MS: m/z Calcd for C 13 
1-(5,8-Dimethoxy-7-methylnaphthalen-2-yl)ethanone (24)
To a solution of compound 20 (100 mg, 0.49 mmol) in CH 2 Cl 2 (15 ml), CH 3 COCl (0.17 ml, 1.69 mmol) and AlCl 3 (220 mg, 1.69 mmol) were added. The mixture was stirred at room temperature for 40 min, then poured into ice-water (50 ml), neutralized with NaHCO 3 and extracted with CHCl 3 (30 mlϫ3). The organic extracts were washed with water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue which was subjected to column chromatography (a gradient of 0-5% acetone in toluene) to obtain compound 24 (78.8 mg, 65.2% yield) as colorless solid (mp 115-116°C). 
5,8-Dimethoxy-7-methylnaphthalene-2-carboxylic Acid (25)
Finely powdered KOH (130 mg, 2.3 mmol) was added to a solution of 24 (100 mg, 0.41 mmol) in DMF (10 ml) and the mixture was then stirred at 68°C for 3 h. After a second addition of finely powderd KOH (130 mg, 2.3 mmol) the mixture was stirred at the same temperature for a further 12 h. The reaction mixture was then poured into ice-water (100 ml) and extracted with CHCl 3 (50 mlϫ3). The chloroform extracts were acidified by addition of 5% aqueous HCl and extracted with CHCl 3 (50 mlϫ3). The extracts were washed with water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue, which was subjected to column chromatography (a gradient of 0-3% MeOH in CHCl 3 (5,8-Dimethoxy-7-methylnaphthalen-2-yl)methanol (26) LiAlH 4 (62.3 mg, 1.64 mmol) was added to a solution of 25 (100 mg, 0.41 mmol) in THF (10 ml) and the mixture was then stirred at room temperature for 12 h. The reaction mixture was neutralized by addition of 10% aqueous H 2 SO 4 , poured into ice-water (100 ml) and extracted with CHCl 3 (50 mlϫ3). The organic extracts were washed with water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue, which was subjected to column chromatography (a gradient of 0-5% acetone in toluene) to obtain compound 26 (61. 1-[(1,4-Dimethoxynaphthalen-2-yl) methyl]-5-methylpyrimidine-2,4(1H,3H)-dione (28) The same reaction and procedure using 19 (80.0 mg, 0.29 mmol), 7 (72.0 mg, 0.57 mmol) and NaH (6.9 mg, 0.29 mmol) as for the preparation of 27 gave a residue, which was subjected to column chromatography (a gradient of 0-20% acetone in toluene) to afford compound 28 (49.9 mg, 53.7% yield) as a solid (mp 208-210°C 9 Hz, 5Ј-CH 3 ). 13 C-NMR (pyridine- 1-[(1,4-Dioxo-1,4-dihydronaphthalen-2-yl) methyl]-5-methylpyrimidine-2,4(1H,3H)-dione (35) To a solution of 28 (45.0 mg, 0.14 mmol) in AcOH (5 ml), HNO 3 (0.28 g, 2.90 mmol) was added, and the mixture was stirred at room temperature for 1 h. The reaction mixture was poured into ice-water (50 ml) and extracted with CHCl 3 (50 mlϫ3). The organic extracts were neutralized with 5% aqueous NaHCO 3 , H-11 ). 13 -1-[(7-methyl-5,8-dioxo-5,8-dihydronapphthalen-2-yl) methyl]pyrimidine-2,4(1H,3H)-dione (41) The same reaction and procedure using 34 (80.0 mg, 0.23 mmol) as described for the preparation of 35 gave a residue, which was subjected to column chromatography (a gradient of 0-5% MeOH in CHCl 3 
5-Fluoro

1-[(1,4-Dimethoxynaphthalen-2-yl)methyl]pyrrolidine (42)
Pyrrolidine (91 ml, 1.1 mmol) was added to a solution of 19 (50 mg, 0.18 mmol) in DMF (10 ml) and the mixture was then stirred at room temperature for 30 min. The reaction mixture was poured into ice-water (100 ml), neutralized with 5% aqueous NaHCO 3 , and extracted with Et 2 O (50 mlϫ3). The organic extracts were washed with water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue, which was subjected to column chromatography (a gradient of 0-5% MeOH in toluene) to obtain compound 42 (31. 13 1-[(1,4-Dimethoxynaphthalen-2-yl) 3H, s, H-11 ). 13 2-[(Pyrrolidin-1-yl)methyl]naphthalene-1,4-dione (51) To a solution of 42 (100 mg, 0.37 mmol) in THF (25 ml) and H 2 O (5 ml), NBS (72.2 mg, 0.41 mmol) and 0.1 M aqueous H 2 SO 4 (0.05 ml) were added, and the mixture was then stirred at room temperature for 5 min. The reaction mixture was poured into ice-water (100 ml), neutralized with 5% aqueous NaHCO 3 , and extracted with Et 2 O (50 mlϫ3). The organic extracts were washed with water, dried over MgSO 4 , and filtered. The filtrate was evaporated to give a residue, which was subjected to column chromatography (a gradient of 0-3% MeOH in CHCl 3 ) to obtain compound 51 (52.9 mg, 59.0% yield). EI-MS: m/z 241 [M] 7-[(1,4-Dioxo-1,4 -dihydronaphthalen-2-yl)methyl]-3,7-dimethyl-3,7dihydro-1H-purine-2,6-dione (55) A solution of 47 (100 mg, 0.26 mmol) and HNO 3 (0.28 g, 2.9 mmol) in AcOH (10 ml) was stirred at room temperature for 1 h. The reaction mixture was poured into ice-water (50 ml), and the mixture was neutralized with 5% aqueous NaHCO 3 , and extracted with CHCl 3 (50 mlϫ3). The extracts were evaporated to give a residue which was subjected to column chromatography (a gradient of 0-3% MeOH in
